{"id":"https://openalex.org/W1990471816","doi":"https://doi.org/10.2174/138161207780618920","title":"The Neurobiological Bases for the Pharmacotherapy of Nicotine Addiction","display_name":"The Neurobiological Bases for the Pharmacotherapy of Nicotine Addiction","alternate_titles":[],"publication_year":2007,"publication_date":"2007-04-01","ids":{"openalex":"https://openalex.org/W1990471816","doi":"https://doi.org/10.2174/138161207780618920","mag":"1990471816","pmid":"https://pubmed.ncbi.nlm.nih.gov/17504235"},"language":"en","primary_location":{"id":"doi:10.2174/138161207780618920","doi":"https://doi.org/10.2174/138161207780618920","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161207780618920","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1990471816"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046342727","display_name":"Vincenzo Di Matteo","orcid":"https://orcid.org/0000-0002-9630-5663","observed_orcids":["https://orcid.org/0000-0002-9630-5663"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vincenzo Di Matteo","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti), Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079852388","display_name":"Massimo Pierucci","orcid":"https://orcid.org/0009-0001-8454-4712","observed_orcids":["https://orcid.org/0009-0001-8454-4712"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Massimo Pierucci","raw_affiliation_strings":["Istituto di Recherche Farmacologiche Mario Negri - Consorzio Mario Negri Sud"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Recherche Farmacologiche Mario Negri - Consorzio Mario Negri Sud","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006777529","display_name":"Giuseppe Di Giovanni","orcid":"https://orcid.org/0000-0003-2006-563X","observed_orcids":["https://orcid.org/0000-0003-2006-563X","https://orcid.org/0009-0003-0122-0654"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giuseppe Di Giovanni","raw_affiliation_strings":["Istituto di Recherche Farmacologiche Mario Negri - Consorzio Mario Negri Sud"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Recherche Farmacologiche Mario Negri - Consorzio Mario Negri Sud","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016629827","display_name":"A Benigno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arcangelo Benigno","raw_affiliation_strings":["Istituto di Recherche Farmacologiche Mario Negri - Consorzio Mario Negri Sud"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Recherche Farmacologiche Mario Negri - Consorzio Mario Negri Sud","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104062079","display_name":"Ennio Esposito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ennio Esposito","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Consorzio \u201cMario Negri\u201d Sud, 66030 Santa Maria Imbaro (Chieti), Italy.,Italy","Istituto di Recherche Farmacologiche Mario Negri - Consorzio Mario Negri Sud"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Consorzio \u201cMario Negri\u201d Sud, 66030 Santa Maria Imbaro (Chieti), Italy.,Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Istituto di Recherche Farmacologiche Mario Negri - Consorzio Mario Negri Sud","institution_ids":["https://openalex.org/I19630809"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I19630809"],"apc_list":null,"apc_paid":null,"fwci":2.0331,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.8627299,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"13","issue":"12","first_page":"1269","last_page":"1284"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.8452000021934509,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.8452000021934509,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.13989999890327454,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nicotine-dependence","display_name":"nicotine dependence","score":0.9959999918937683},{"id":"https://openalex.org/keywords/mesolimbic-dopamine-system","display_name":"mesolimbic dopamine system","score":0.8299999833106995},{"id":"https://openalex.org/keywords/nicotinic-acetylcholine-receptors","display_name":"nicotinic acetylcholine receptors","score":0.8999999761581421},{"id":"https://openalex.org/keywords/substantia-nigra-pars-compacta","display_name":"substantia nigra pars compacta","score":0.8550000190734863},{"id":"https://openalex.org/keywords/ventral-tegmental-area","display_name":"ventral tegmental area","score":1.0},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.9739999771118164},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.9210000038146973},{"id":"https://openalex.org/keywords/locomotor-activation","display_name":"locomotor activation","score":0.6579999923706055},{"id":"https://openalex.org/keywords/drug-reinforcement","display_name":"drug reinforcement","score":0.8479999899864197},{"id":"https://openalex.org/keywords/nicotine-dependence-treatment","display_name":"tobacco dependence treatment","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.8429328203201294},{"id":"https://openalex.org/C2780948874","wikidata":"https://www.wikidata.org/wiki/Q640562","display_name":"Ventral tegmental area","level":4,"score":0.8014741539955139},{"id":"https://openalex.org/C2779547902","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine","level":2,"score":0.7805105447769165},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.7155940532684326},{"id":"https://openalex.org/C2776773494","wikidata":"https://www.wikidata.org/wiki/Q3366041","display_name":"Pars compacta","level":5,"score":0.696537971496582},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.6705033183097839},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.6186659336090088},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.57832932472229},{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.47316867113113403},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4679590165615082},{"id":"https://openalex.org/C85714458","wikidata":"https://www.wikidata.org/wiki/Q17152690","display_name":"Medium spiny neuron","level":4,"score":0.46499577164649963},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.4292592704296112},{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.4105483293533325},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34379708766937256},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33660784363746643},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3012412190437317},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28317877650260925},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26459378004074097},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20534926652908325},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.185185045003891}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009538","descriptor_name":"Nicotine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014029","descriptor_name":"Tobacco Use Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014029","descriptor_name":"Tobacco Use Disorder","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018733","descriptor_name":"Nicotinic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018733","descriptor_name":"Nicotinic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2174/138161207780618920","doi":"https://doi.org/10.2174/138161207780618920","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161207780618920","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:17504235","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17504235","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unipa.it:10447/17063","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10447/17063","pdf_url":null,"source":{"id":"https://openalex.org/S4306401065","display_name":"Nova Science Publishers (Nova Science Publishers, Inc.)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7071250047","https://openalex.org/W83920476","https://openalex.org/W2078420847","https://openalex.org/W1905817477","https://openalex.org/W2277677491","https://openalex.org/W75771940","https://openalex.org/W197849700","https://openalex.org/W196491893","https://openalex.org/W2182368527","https://openalex.org/W3016771099"],"abstract_inverted_index":{"Nicotine,":[0],"the":[1,33,37,50,69,73,92,99,106,113,127,131,143,151,153,160,166,170,179,208,218],"major":[2],"psychoactive":[3],"agent":[4],"present":[5],"in":[6,15,64,68,105,126,150,156],"tobacco,":[7],"acts":[8],"as":[9,165],"a":[10,192],"potent":[11],"addictive":[12],"drug":[13],"both":[14],"humans":[16],"and":[17,36,72,96,112,118,130,155,169,217],"laboratory":[18],"animals,":[19],"whose":[20],"locomotor":[21,34],"activity":[22,101],"is":[23,56],"also":[24],"stimulated.":[25],"A":[26],"large":[27],"body":[28],"of":[29,40,79,102,145,159,175,182,184,194,225],"evidence":[30,176],"indicates":[31],"that":[32,60,178],"activation":[35],"reinforcing":[38,180],"effects":[39,48],"nicotine":[41,61,80,212,226],"may":[42,198],"be":[43,189,215,229],"related":[44],"to":[45,90,97],"its":[46,88,120],"stimulatory":[47,77,121],"on":[49,81,123],"mesolimbic":[51],"dopaminergic":[52,162,203],"function.":[53,204],"Thus,":[54],"it":[55],"now":[57],"well":[58],"established":[59],"can":[62,188],"increase":[63,98],"vivo":[65],"DA":[66,82,103,124],"outflow":[67],"nucleus":[70,132,171],"accumbens":[71],"corpus":[74,128,167],"striatum.":[75],"The":[76,134],"effect":[78],"release":[83],"most":[84],"probably":[85],"results":[86],"from":[87,119],"ability":[89],"excite":[91],"neuronal":[93],"firing":[94],"rate":[95],"bursting":[100],"neurons":[104],"substantia":[107],"nigra":[108],"pars":[109],"compacta":[110],"(SNc)":[111],"ventral":[114],"tegmental":[115],"area":[116],"(VTA),":[117],"action":[122],"terminals":[125],"striatum":[129,168],"accumbens.":[133,172],"neurochemical":[135],"data":[136],"are":[137],"consistent":[138],"with":[139],"neuroanatomical":[140],"findings":[141],"showing":[142],"presence":[144],"nicotinic":[146],"acetylcholine":[147],"receptors":[148],"(nAChRs)":[149],"SNc,":[152],"VTA,":[154],"projection":[157],"areas":[158],"central":[161,202],"system":[163],"such":[164],"Several":[173],"lines":[174],"indicate":[177],"properties":[181],"drugs":[183],"abuse,":[185],"including":[186],"nicotine,":[187],"affected":[190],"by":[191,200],"number":[193],"transmitter":[195],"systems":[196],"which":[197],"act":[199],"modulating":[201],"In":[205],"this":[206],"paper,":[207],"neurobiological":[209],"mechanisms":[210],"underlying":[211],"addiction":[213],"will":[214,228],"reviewed,":[216],"possible":[219],"strategies":[220],"for":[221],"new":[222],"pharmacological":[223],"treatments":[224],"dependence":[227],"examined.":[230]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1990471816","counts_by_year":[{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
